Category: Healthcare and Pharmaceutical

Pill-Shaped Acrylic Tombstone

Pill-shaped Lucite tombstone commemorating a strategic investment by Gauge Capital in Veridicus Health. Based in Salt Lake City, Veridicus is a provider of comprehensive and customizable pharmacy and care management solutions.

1 Image

Research Joint Venture Commemorative

Lucite commemorative marking the joint venture between Emory University and bio-analytical testing firm Euro-Fins. The collaboration will center on Atlanta-based Emory Genetics Laboratory, which has special expertise in researching rare genetic disorders.

1 Image

Intellectual Property Agreement Commemorative

Lucite commemorative marking the acquisition of intellectual property from Interpharm Development by drug delivery firm Catalent. The agreement centers on the development of Vegicaps, a softgel capsule technology that is both all-natural and GMO free.

1 Image

Healthcare Partnership Commemorative

Lucite commemorative marking partnership between Optimhealthcare and National Surgical Healthcare.

1 Image

Water Filtration Deal Tombstone

Deal tombstone recognizing an investment in water filtration manufacturing company Water Shark Systems. The company is headquartered in North Las Vegas, Nevada.

1 Image

Lucite Pill Bottle Marking IPO

Lucite pill bottle marking the initial public offering of nutritional products firm Vitaco. The company is based in Auckland, New Zealand.

1 Image

Commemorative for Pharmaceutical Collaboration

Lucite commemorative marking the research, development, and commercialization  agreement between Sanofi and Regenereon. The pharmaceutical firms will focus on antibody cancer treatment s in the field of immuno-oncology.

1 Image

Biotech IPO Tombstone

Lucite tombstone celebrating the initial public offering of biotech company Chiasma. The Massachusetts-based firm specializes in oral therapies for orphan diseases.

1 Image

Biotech Custom Lucite

Custom Lucite commemorating the private placement of shares issued by Cellectar. Madison, Wisconsin-based Cellectar focuses on developing cancer drugs and imaging tools.

1 Image